170 related articles for article (PubMed ID: 31808315)
1. An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study.
Romano MR; Parolini B; Allegrini D; Michalewska Z; Adelman R; Bonovas S; Bopp S;
Acta Ophthalmol; 2020 Aug; 98(5):e549-e558. PubMed ID: 31808315
[TBL] [Abstract][Full Text] [Related]
2. Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
Breukink MB; Mohr JK; Ossewaarde-van Norel A; den Hollander AI; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Mar; 94(2):187-97. PubMed ID: 26670630
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety between subthreshold micropulse laser, standard-fluence and low-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Altinel MG; Kanra AY; Totuk OMG; Ardagil A; Turkmen OF
J Fr Ophtalmol; 2021 Apr; 44(4):499-508. PubMed ID: 33642060
[TBL] [Abstract][Full Text] [Related]
4. Crossover to PDT after the unsuccessful micropulse laser treatment of central serous chorioretinopathy.
Gawęcki M; Kiciński K; Grzybowski A
Adv Ophthalmol Pract Res; 2024; 4(1):32-38. PubMed ID: 38406665
[TBL] [Abstract][Full Text] [Related]
5. Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy.
Zeng M; Chen X; Song Y; Cai C
BMC Ophthalmol; 2022 Mar; 22(1):110. PubMed ID: 35260118
[TBL] [Abstract][Full Text] [Related]
6. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
Enders C; Lang GE; Mayer B; Werner JU
Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Lai FH; Ng DS; Bakthavatsalam M; Chan VC; Young AL; Luk FO; Tsang CW; Brelén ME
Am J Ophthalmol; 2016 Oct; 170():91-99. PubMed ID: 27519561
[TBL] [Abstract][Full Text] [Related]
8. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Cheng CK; Chang CK; Peng CH
Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
[TBL] [Abstract][Full Text] [Related]
9. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
Arevalo JF; Espinoza JV
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1159-66. PubMed ID: 21448811
[TBL] [Abstract][Full Text] [Related]
10. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
[TBL] [Abstract][Full Text] [Related]
11. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
[TBL] [Abstract][Full Text] [Related]
12. [Observation on long-term efficacy of half-dose photodynamic therapy with chronic central serous chorioretinopathy using optical coherence tomography].
Liu Y; Li L; Xu G; Wang W
Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):328-34. PubMed ID: 27220704
[TBL] [Abstract][Full Text] [Related]
13. Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function.
Gawęcki M; Jaszczuk A; Grzybowski A
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114519
[No Abstract] [Full Text] [Related]
14. Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy.
Müller B; Tatsios J; Klonner J; Pilger D; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1581-1588. PubMed ID: 29876733
[TBL] [Abstract][Full Text] [Related]
15. Three-Year Results of Fluorescein Angiography-Guided Standard Photodynamic Therapy with Multiple Spots for Central Serous Chorioretinopathy.
Ladas ID; Andreanos KD; Ladas DS; Moschos MM; Rotsos T; Kotsolis AI
Ophthalmol Retina; 2018 Jul; 2(7):703-711. PubMed ID: 31047379
[TBL] [Abstract][Full Text] [Related]
16. Central serous chorioretinopathy: what we have learnt so far.
Wong KH; Lau KP; Chhablani J; Tao Y; Li Q; Wong IY
Acta Ophthalmol; 2016 Jun; 94(4):321-5. PubMed ID: 26132864
[TBL] [Abstract][Full Text] [Related]
17. A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.
Bae SH; Heo JW; Kim C; Kim TW; Lee JY; Song SJ; Park TK; Moon SW; Chung H
Am J Ophthalmol; 2011 Nov; 152(5):784-92.e2. PubMed ID: 21742303
[TBL] [Abstract][Full Text] [Related]
18. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY VERSUS PHOTODYNAMIC THERAPY IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO CENTRAL SEROUS CHORIORETINOPATHY.
Peiretti E; Caminiti G; Serra R; Querques L; Pertile R; Querques G
Retina; 2018 Aug; 38(8):1526-1532. PubMed ID: 28699928
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis.
Aisu N; Miyake M; Hosoda Y; Mori Y; Takahashi A; Muraoka Y; Ueda-Arakawa N; Miyata M; Oishi A; Tamura H; Ooto S; Yamashiro K; Tsujikawa A
Ophthalmol Sci; 2022 Jun; 2(2):100152. PubMed ID: 36249695
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of focal laser photocoagulation and photodynamic therapy for the treatment of central serous chorioretinopathy.
Shin YI; Kim KM; Lee MW; Kim JY; Jo YJ
Jpn J Ophthalmol; 2020 Jan; 64(1):28-36. PubMed ID: 31863228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
